Concepedia

Publication | Open Access

<p>FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer</p>

DOIFull Paper Access

45

Citations

31

References

2020

Year

Yihong Chen, Ganlu Deng, Yaojie Fu, Ying Han, Cao Guo, Ling Yin, Changjing Cai, Hong Shen, Shaobin Wu, Shan Zeng
OncoTargets and Therapy

Abstract

FOXC2 induced EMT to promote oxaliplatin resistance by activating the MAPK/ERK signaling pathway. FOXC2 may be a potential therapeutic target for overcoming OXA resistance in human CRC.

References

YearCitations

Page 1